B. Buckingham

发表

Inpatient Studies of a Kalman-Filter-Based Predictive Pump Shutoff Algorithm

Darrell M. Wilson, B. Bequette, F. Cameron, 2012, Journal of diabetes science and technology.

A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes

Darrell M. Wilson, B. Bequette, R. Beck, 2014, Diabetes Care.

A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator

Darrell M. Wilson, B. Bequette, B. Buckingham, 2009, Journal of diabetes science and technology.

Detection of a Meal Using Continuous Glucose Monitoring

F. Doyle, B. Bequette, E. Dassau, 2008, Diabetes Care.

Probabilistic Evolving Meal Detection and Estimation of Meal Total Glucose Appearance

G. Niemeyer, F. Cameron, B. Buckingham, 2009, Journal of diabetes science and technology.

Statistical Hypoglycemia Prediction

Günter Niemeyer, Karen Gundy-Burlet, Fraser Cameron, 2008, Journal of diabetes science and technology.

Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension.

F. Cameron, B. Buckingham, Paula K Clinton, 2009, Diabetes technology & therapeutics.

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Benyamin Grosman, Bruce A. Buckingham, Stacey M. Anderson, 2017, Diabetes technology & therapeutics.

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report

F. Doyle, A. Çinar, R. Hovorka, 2016, Diabetes Care.

Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline.

D. Klonoff, R. Vigersky, B. Buckingham, 2011, The Journal of clinical endocrinology and metabolism.

Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

F. Doyle, B. Bequette, E. Dassau, 2010, Diabetes Care.

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes.

Darrell M. Wilson, B. Buckingham, Elizabeth L Kunselman, 2005, Diabetes care.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

F. Doyle, C. Cobelli, R. Hovorka, 2019, Diabetes Care.

Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia.

Darrell M. Wilson, B. Bequette, R. Beck, 2013, Diabetes technology & therapeutics.

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).

D. Klonoff, R. Beck, B. Buckingham, 2013, Diabetes technology & therapeutics.

Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring

Eyal Dassau, Francis J. Doyle, B. Wayne Bequette, 2010, Diabetes Care.

The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes

B Wayne Bequette, Bruce A Buckingham, Darrell M Wilson, 2014, Journal of diabetes science and technology.

Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia

Darrell M. Wilson, A. Reiss, R. Beck, 2014, Diabetes.

Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm.

Bruce Buckingham, Darrell M Wilson, Darrell M. Wilson, 2007, Diabetes technology & therapeutics.

Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.

Bruce A Buckingham, Roy W Beck, Dongyuan Xing, 2005, Diabetes technology & therapeutics.

Ultra-fast insulin-pramlintide co-formulation for improved glucose management in diabetic rats

B. Buckingham, D. Maahs, Eric A. Appel, 2021, bioRxiv.

Clinical Practice Consensus Guidelines 2018 : Insulin treatment in children and adolescents with diabetes

B. Buckingham, M. Phillip, T. Danne, 2018 .

Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.

Bruce Buckingham, B. Buckingham, T. Aye, 2010, Endocrinology and metabolism clinics of North America.

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

Christopher G. Parkin, Bruce A. Buckingham, Irl B. Hirsch, 2008, Diabetes technology & therapeutics.

Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile

David C Klonoff, Bruce Buckingham, Irl B Hirsch, 2013, Journal of diabetes science and technology.

The extended Kalman filter for continuous glucose monitoring.

B. Buckingham, E. Knobbe, 2005, Diabetes technology & therapeutics.

Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm

Darrell M. Wilson, B. Bequette, F. Cameron, 2012 .

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial.

Bruce A Buckingham, David M Maahs, Laya Ekhlaspour, 2019, Diabetes technology & therapeutics.

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

B. Buckingham, M. A. Wood, T. Bailey, 2019, Diabetes technology & therapeutics.

Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp

B. Buckingham, M. Breton, T. Ly, 2016, Diabetes Care.

International Consensus on Use of Continuous Glucose Monitoring

Eyal Dassau, Claudio Cobelli, Roman Hovorka, 2017, Diabetes Care.

Predictive hyperglycemia and hypoglycemia minimization: In‐home double‐blind randomized controlled evaluation in children and young adolescents

Gregory P. Forlenza, Darrell M. Wilson, B. Bequette, 2018, Pediatric diabetes.

Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline

R. Hovorka, D. Klonoff, B. Buckingham, 2020, Journal of diabetes science and technology.

Relationship between the content of lysyl oxidase-dependent cross-links in skin collagen, nonenzymatic glycosylation, and long-term complications in type I diabetes mellitus.

B. Buckingham, K. Reiser, K M Reiser, 1990, The Journal of clinical investigation.

Scleroderma-like Changes in Insulin-dependent Diabetes Mellitus: Clinical and Biochemical Studies

B. Buckingham, C. Sandborg, J. Uitto, 1984, Diabetes Care.

Analysis: dawn of real-time continuous glucose sensing.

B. Buckingham, 2003, Diabetes technology & therapeutics.

Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197–1204

Darrell M. Wilson, B. Bequette, R. Beck, 2015, Diabetes Care.

Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes

Darrell M. Wilson, R. Beck, B. Buckingham, 2016, Journal of diabetes science and technology.

Diabetes technology and the human factor

B. Buckingham, M. Phillip, A. Liberman, 2012, International journal of clinical practice. Supplement.

Technology and the Human Factor

B. Buckingham, M. Phillip, A. Liberman, 2011 .

The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia

D. Klonoff, B. Buckingham, R. Slover, 2011, Journal of diabetes science and technology.

Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.

Darrell M. Wilson, R. Beck, B. Buckingham, 2015, Diabetes technology & therapeutics.

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.

Bruce Buckingham, David M Maahs, Laura Pyle, 2016, Diabetes technology & therapeutics.

Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report

R. Vigersky, B. Buckingham, J. Pickup, 2022, Journal of diabetes science and technology.

Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial

R. Vigersky, B. Buckingham, Y. Kudva, 2022, Diabetes technology & therapeutics.

Longevity of the novel ConvaTec infusion set with Lantern technology

B. Buckingham, R. Lal, Liana J. Hsu, 2021, Diabetes, obesity & metabolism.

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes

B. Buckingham, D. Maahs, R. Wadwa, 2015, Diabetes Care.

Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.

Günter Niemeyer, B Wayne Bequette, Bruce A Buckingham, 2014, Diabetes technology & therapeutics.

Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days

B. Buckingham, D. Maahs, R. Wadwa, 2016, Diabetes Care.

Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users

B. Buckingham, D. Maahs, S. Weinzimer, 2020, Journal of health psychology.

Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers

B. Buckingham, R. Wadwa, M. Breton, 2020, Diabetes technology & therapeutics.

Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All.

Darrell M. Wilson, B. Buckingham, D. Maahs, 2018, Diabetes technology & therapeutics.

Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics

A. McCall, R. Beck, Aaron J. Kowalski, 2018, Diabetes Care.

Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation versus Sensor-Augmented Pump: Results from the International Diabetes Closed Loop Trial 4 (DCLP4).

Mei Mei Church, E. Dassau, B. Buckingham, 2022, Diabetes technology & therapeutics.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.

Mei Mei Church, F. Doyle, C. Cobelli, 2019, Diabetes technology & therapeutics.

Ultra‐Fast Insulin–Pramlintide Co‐Formulation for Improved Glucose Management in Diabetic Rats

B. Buckingham, D. Maahs, Eric A. Appel, 2021, Advanced science.

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

Claudio Cobelli, Lalo Magni, Francis J Doyle, 2014, Diabetes technology & therapeutics.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes

Lauren M. Huyett, Joon Bok Lee, E. Dassau, 2018, Diabetes technology & therapeutics.

Multinational Home Use of Closed-Loop Control Is Safe and Effective

Marc D. Breton, Eyal Dassau, Francis J. Doyle, 2016, Diabetes Care.

Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting

B. Buckingham, Paula K Clinton, F. El-Khatib, 2019, Journal of diabetes science and technology.

Remote glucose monitoring in cAMP setting reduces the risk of prolonged nocturnal hypoglycemia.

Darrell M. Wilson, B. Buckingham, Paula K Clinton, 2014, Diabetes technology & therapeutics.

Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.

B. Buckingham, I. Hirsch, T. Peyser, 2017, Diabetes technology & therapeutics.

Automation of a multiplex agglutination-PCR (ADAP) type 1 diabetes (T1D) assay for the rapid analysis of islet autoantibodies.

Darrell M. Wilson, B. Buckingham, D. Maahs, 2021, SLAS technology.

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

Darrell M. Wilson, B. Buckingham, D. Maahs, 2020, PloS one.

International Society for Pediatric and Adolescent Diabetes (ISPAD)

Louisa, Aaron J. Kowalski, B. Buckingham, 2006 .

Functional near‐infrared spectroscopy detects increased activation of the brain frontal‐parietal network in youth with type 1 diabetes

A. Reiss, L. Foland-Ross, B. Buckingham, 2020, Pediatric diabetes.

Type 1 Diabetes Mellitus and Epilepsia Partialis Continua in a 6-Year-Old Boy With Elevated Anti-GAD 65 Antibodies

B. Buckingham, C. Sandborg, D. Olson, 2002 .

Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies.

B. Buckingham, C. Sandborg, D. Olson, 2002, Pediatrics.

Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes

Darrell M. Wilson, R. Beck, B. Tallant, 2007, Pediatric diabetes.

Measures from Nonlinear Dynamics Reflect Glucose Current Sensor Degradation

B. Buckingham, A. Mandell, Eric Mauritzen, 2016 .

A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring.

Darrell M. Wilson, B. Buckingham, Laura M. Nally, 2019, Diabetes technology & therapeutics.

The surgical management of hyperinsulinism in infancy due to nesidioblastosis.

B. Buckingham, J. C. German, M. J. Warden, 1988, Journal of pediatric surgery.

Hyperthyroidism in children. A reevaluation of treatment.

B. Buckingham, M. Kogut, G. Costin, 1981, American journal of diseases of children.

The Hyperthyroid Fetus and Infant

B. Buckingham, 2000 .

Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry

R. Beck, B. Buckingham, D. Maahs, 2015, Journal of diabetes.

Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study.

D. Klonoff, B. Buckingham, R. Slover, 2014, Diabetes technology & therapeutics.

100-LB: Infusion Set Survival and Performance during the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial

R. Vigersky, B. Buckingham, Y. Kudva, 2021, Diabetes.

Advances in Insulin Pump Infusion Sets Symposium Report

D. Klonoff, R. Vigersky, B. Buckingham, 2021, Journal of diabetes science and technology.

Large Changes in Brain Volume Observed in an Asymptomatic Young Child With Type 1 Diabetes

A. Reiss, B. Buckingham, T. Aye, 2018, Diabetes Care.

Adiponectin and catecholamine concentrations during acute exercise in children with type 1 diabetes

R. Beck, B. Buckingham, W. Tamborlane, 2008, Pediatric diabetes.

Insulin pumps in young children.

Darrell M. Wilson, B. Buckingham, B. Conrad, 2010, Diabetes technology & therapeutics.

Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus

B. Buckingham, K. Chandy, Sudhir Gupta, 1984, Journal of Clinical Immunology.

Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB.

B. Buckingham, C. Ding, M. Levine, 2001, The Journal of clinical investigation.

Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study

A. Reiss, L. Foland-Ross, B. Buckingham, 2021, Diabetes Care.

Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.

B. Buckingham, C. Sandborg, F. Zaldivar, 1996, Journal of immunology.

A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus.

B. Buckingham, C. Sandborg, 2000, Clinical immunology.

Complement activation in type 1 human diabetes.

B. Buckingham, L. Wood, M. Charles, 1985, Clinical immunology and immunopathology.

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.

Eyal Dassau, Francis J. Doyle, Ravi Gondhalekar, 2017, Diabetes technology & therapeutics.

The Effect of Thyroxine Treatment Started in the Neonatal Period on Development and Growth of Two-Year-Old Down Syndrome Children: A Randomized Clinical Trial

B. Buckingham, 2006 .

Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial.

R. Hovorka, M. Wilinska, R. Beck, 2022, The Lancet. Digital health.

Natural killer cell and islet killer cell activities in Type 1 (insulin-dependent) diabetes

B. Buckingham, G. Chandy, M. Charles, 1986, Diabetologia.

Diabetes Technology and the Human Factor.

B. Buckingham, A. Liberman, 2016, Diabetes technology & therapeutics.

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

Mei Mei Church, F. Doyle, E. Dassau, 2020, Diabetes Care.

Improving Patient Experience With Insulin Infusion Sets

Alison B. Evert, B. Buckingham, I. Hirsch, 2016, The Diabetes educator.

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial

B. Buckingham, G. Forlenza, B. Bode, 2022, Diabetes care.

Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes

R. Beck, B. Buckingham, R. Wadwa, 2020, Diabetes Care.

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.

R. Beck, B. Buckingham, R. Wadwa, 2020, The New England journal of medicine.

Fast-Acting Insulin Aspart Use with the MiniMed™ 670G System.

B. Buckingham, R. Von Eyben, R. Lal, 2020, Diabetes technology & therapeutics.

Vitamin D Deficiency in the San Francisco Bay Area

B. Buckingham, A. Lane, J. C. McAllister, 2006, Journal of pediatric endocrinology & metabolism : JPEM.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes

Dennis R Harris, B. Buckingham, G. Forlenza, 2017, Journal of the Endocrine Society.

Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus.

B. Buckingham, K. Chandy, M. Charles, 1984, Immunology letters.

Interferon responsiveness of natural killer cells in type I human diabetes.

B. Buckingham, K. Chandy, M. Charles, 1988, Diabetes research.

Natural killer cell and islet killer cell activities in human type 1 diabetes.

B. Buckingham, G. Chandy, S. Gupta, 2009, Experimental and clinical endocrinology.

Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial

B. Buckingham, L. Dimeglio, G. Forlenza, 2022, Pediatric diabetes.

Studies of immune-complex glomerulonephritis mediated by human thyroglobulin.

B. Buckingham, S. Jordan, D. Olson, 1981, The New England journal of medicine.

Prevention of type 1a diabetes mellitus *

Darrell M. Wilson, B. Buckingham, B. Buckingham, 2001, Pediatric diabetes.

Prevention of type 1 diabetes mellitus.

Darrell M. Wilson, B. Buckingham, 2000, Diabetes care.

Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.

R. Beck, B. Buckingham, P. Calhoun, 2022, Diabetes technology & therapeutics.

Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.

R. Beck, B. Buckingham, P. Calhoun, 2022, Diabetes technology & therapeutics.

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm

Joon Bok Lee, E. Dassau, B. Buckingham, 2018, Diabetes technology & therapeutics.

Heterogeneity in the Specificity of the Islet Cell Cytoplasmic Antibody Response in Insulin‐Dependent Diabetes Mellitus

B. Buckingham, A. Kershnar, D. Kawahara, 1990, Pancreas.

1103 SCLERODERMA-LIKE SYNDROME AND THE NON-ENZYMATIC GLUCOSYLATION OF COLLAGEN IN CHILDREN WITH POORLY CONTROLLED INSULIN DEPENDENT DIABETES (IDDM)

B. Buckingham, C. Sandborg, J. Uitto, 1981, Pediatric Research.

Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.

B. Buckingham, M. Charles, A. Kershnar, 1983, Journal of immunology.

Acceptability and Utility of the mySentry Remote Glucose Monitoring System

B. Buckingham, R. Slover, J. Welsh, 2013, Journal of diabetes science and technology.

Title: Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children with Type 1 Diabetes: Association with Hyperglycemia Short Title: Brain Changes in Young Children with T1D

Darrell M. Wilson, A. Reiss, R. Beck, 2014 .

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances meal-time glucagon suppression in diabetic pigs

Sam W. Baker, B. Buckingham, D. Maahs, 2020, Nature Biomedical Engineering.

Skin, joint, and pulmonary changes in type I diabetes mellitus.

B. Buckingham, C. Sandborg, J. Uitto, 1986, American journal of diseases of children.

Pathologic and immune factors in thyroid disease.

B. Buckingham, M. Kogut, G. Costin, 1977, The Journal of pediatrics.

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting

Bruce Buckingham, Laura Pyle, David M. Maahs, 2015, Diabetes Care.

Thyroidectomy for hyperthyroidism in children.

B. Buckingham, R. Andrassy, J. Weitzman, 1980, Journal of pediatric surgery.

Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis

B. Buckingham, W. Tamborlane, C. Kollman, 2014, Pediatric diabetes.

Successfully Treated With Intravenously Administered Pamidronate Severe Infantile Hypercalcemia Associated With Williams Syndrome

B. Buckingham, L. Dimeglio, R. Shankar, 2013 .

Severe Infantile Hypercalcemia Associated With Williams Syndrome Successfully Treated With Intravenously Administered Pamidronate

B. Buckingham, L. Dimeglio, R. Shankar, 2004, Pediatrics.

White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study

Allan L. Reiss, Bruce A. Buckingham, Darrell M. Wilson, 2012, Diabetes Care.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Eyal Dassau, Francis J Doyle, Lori M Laffel, 2019, The New England journal of medicine.

Evaluation of factors affecting CGMS calibration.

Bruce A Buckingham, Darrell M Wilson, Roy Beck, 2006, Diabetes technology & therapeutics.

Rhabdomyolysis in diabetic ketoacidosis.

B. Buckingham, J. Yoon, T. Roe, 1981, American journal of diseases of children.

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data

Thomas A. Peyser, Bruce A. Buckingham, Arturo Garcia, 2018, Diabetes technology & therapeutics.

Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes

Darrell M. Wilson, A. Reiss, M. Raman, 2015, Diabetes.

Cognitive and Behavioral Characteristics of Turner Syndrome: Exploring a Role for Ovarian Hormones in Female Sexual Differentiation

B. Buckingham, M. Hines, M. L. Collaer, 2002, Hormones and Behavior.

Use of continuous glucose monitoring in children and adolescents *

B. Buckingham, S. Shalitin, M. Phillip, 2012, Pediatric diabetes.

Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Stephen D Patek, B Wayne Bequette, Nihat Baysal, 2018, Diabetes technology & therapeutics.

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.

Daniel Howsmon, Stephen D Patek, B Wayne Bequette, 2017, Diabetes technology & therapeutics.

Algorithms for a Single Hormone Closed-Loop Artificial Pancreas: Challenges Pertinent to Chemical Process Operations and Control

B. Wayne Bequette, Faye Cameron, Nihat Baysal, 2016, Processes.

Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.

Bruce Buckingham, Laya Ekhlaspour, Korey Hood, 2019, Endocrine reviews.

Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).

Howard Wolpert, William L Clarke, Bruce Buckingham, 2008, Diabetes technology & therapeutics.

Real-time continuous glucose monitoring

Bruce Buckingham, Darrell M Wilson, Darrell M. Wilson, 2007, Current opinion in endocrinology, diabetes, and obesity.

Self-care behaviors in insulin-dependent diabetes: evaluative tools and their associations with glycemic control.

B. Buckingham, O. Kolterman, M. De Guire, 1996, Journal of pediatric psychology.

Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]

C. de Beaufort, Aaron J. Kowalski, B. Buckingham, 2021, Diabetologia.

Mevalonate kinase deficiency in a dizygotic twin with mild mevalonic aciduria

B. Buckingham, K. Gibson, G. Hoffmann, 1997, Journal of Inherited Metabolic Disease.

Thyroid function in children with chronic renal failure.

B. Buckingham, R. Fine, A. Pennisi, 1977, Nephron.

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

David C Klonoff, Bruce A Buckingham, Timothy S Bailey, 2012, Diabetes technology & therapeutics.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes

Howard Wolpert, Michael J. O'Grady, Bruce A. Buckingham, 2009 .

Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group

Howard Wolpert, Bruce Buckingham, Tim Wysocki, 2008 .

Intensive Care Unit Insulin Delivery Algorithms: Why So Many? How to Choose?

Bruce Buckingham, Garry M. Steil, Stuart Weinzimer, 2009, Journal of diabetes science and technology.

Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.

R. Beck, B. Buckingham, W. Tamborlane, 2013, Diabetes technology & therapeutics.

Diabetes technology and the human factor.

Bruce Buckingham, Moshe Phillip, B. Buckingham, 2013, Diabetes technology & therapeutics.

A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery

Bruce Buckingham, Laya Ekhlaspour, Ideen Tabatabai, 2019, Journal of diabetes science and technology.

The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis.

R. Beck, B. Buckingham, R. Slover, 2013, Diabetes technology & therapeutics.

Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study.

Bruce A Buckingham, H Peter Chase, Stuart A Weinzimer, 2005, Diabetes technology & therapeutics.

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.

Bruce W Bode, Bruce A Buckingham, Stuart A Weinzimer, 2016, JAMA.

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis

B. Wayne Bequette, Bruce A. Buckingham, David M. Maahs, 2015, Diabetes Care.

Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents

Janet M. Allen, R. Hovorka, M. Wilinska, 2022, Diabetes, obesity & metabolism.

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System

Darrell M. Wilson, B. Buckingham, D. Maahs, 2019, Diabetes Care.

Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System

B. Buckingham, D. Maahs, S. Weinzimer, 2017, The Diabetes educator.

Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial

Eyal Dassau, Francis J. Doyle, B. Wayne Bequette, 2017, Diabetes Care.

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

Bruce A Buckingham, Darrell M Wilson, M Sue Kirkman, 2017, The Lancet.

Association of Hypoglycemia, Hyperglycemia, and Glucose Variability With Morbidity and Death in the Pediatric Intensive Care Unit

Bruce Buckingham, Darrell M Wilson, Darrell M. Wilson, 2006, Pediatrics.

Full closed loop open‐source algorithm performance comparison in pigs with diabetes

Sam W. Baker, B. Buckingham, D. Maahs, 2021, Clinical and Translational Medicine.

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions

Lauren M. Huyett, Joon Bok Lee, B. Buckingham, 2020, Diabetes technology & therapeutics.

127-LB: Longevity of the Coated ConvaTec Infusion Set with Lantern Technology

B. Buckingham, R. Lal, Liana J. Hsu, 2019, Diabetes.

Randomized trial of infusion set function: steel versus teflon.

Bruce A Buckingham, Darrell M Wilson, Darrell M. Wilson, 2014, Diabetes technology & therapeutics.

A Novel Method to Detect Pressure-Induced Sensor Attenuations (PISA) in an Artificial Pancreas

B Wayne Bequette, Nihat Baysal, Fraser Cameron, 2014, Journal of diabetes science and technology.

DiAs Web Monitoring: A Real-Time Remote Monitoring System Designed for Artificial Pancreas Outpatient Trials

Boris Kovatchev, Eric Renard, Bruce Buckingham, 2013, Journal of diabetes science and technology.

Predicting Success with a First-Generation Hybrid Closed Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: a Model Development and Validation Study.

Darrell M. Wilson, B. Buckingham, D. Maahs, 2021, Diabetes technology & therapeutics.

Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop (iDCL) Trial.

B. Buckingham, J. Lum, Sue A Brown, 2022, Diabetes technology & therapeutics.

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances meal-time glucagon suppression in diabetic pigs

Sam W. Baker, B. Buckingham, D. Maahs, 2020, Nature Biomedical Engineering.

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.

M. Phillip, R. Beck, J. Rosenstock, 2022, The lancet. Diabetes & endocrinology.

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system

B. Buckingham, D. Maahs, R. Wadwa, 2019, Pediatric diabetes.

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes

Lauren M. Huyett, Joon Bok Lee, E. Dassau, 2019, Diabetes technology & therapeutics.

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

Gregory P. Forlenza, Bruce A. Buckingham, David M. Maahs, 2018, Diabetes Care.

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial

Gregory P. Forlenza, Bruce A. Buckingham, Laya Ekhlaspour, 2018, Diabetes Care.

Continuous Glucose Monitoring: Current Use and Future Directions

Bruce Buckingham, B. Buckingham, D. DeSalvo, 2013, Current Diabetes Reports.

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

B. Buckingham, I. Hirsch, R. Bergenstal, 2021, Diabetes Care.

Engineering biopharmaceutical formulations to improve diabetes management

B. Buckingham, Eric A. Appel, R. Lal, 2021, Science Translational Medicine.

Behavioral, Metabolic, and Enzymatic Studies of a Brain Indoleethylamine N-Methylating System

B. Buckingham, A. Mandell, D. Segal, 1971 .

The Feasibility of Detecting Neuropsychologic and Neuroanatomic Effects of Type 1 Diabetes in Young Children

Darrell M. Wilson, A. Reiss, S. Kesler, 2011, Diabetes Care.

Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas.

Gregory P. Forlenza, Bruce A. Buckingham, David M. Maahs, 2016, The Journal of pediatrics.

Advances in Care for Insulin-Requiring Patients Without Closed Loop.

Bruce Buckingham, David M Maahs, B. Buckingham, 2018, Diabetes technology & therapeutics.

Relative accuracy of the BD Logic and FreeStyle blood glucose meters.

R. Beck, B. Buckingham, W. Tamborlane, 2007, Diabetes technology & therapeutics.

Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp

Marc D. Breton, Boris P. Kovatchev, Bruce A. Buckingham, 2014, Diabetes Care.

Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus.

Bruce A Buckingham, H Peter Chase, Tim Wysocki, 2005, The Journal of pediatrics.

Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes

Darrell M. Wilson, R. Beck, B. Buckingham, 2011, Diabetes Care.

Implications of Meal Library & Meal Detection to Glycemic Control of Type 1 Diabetes Mellitus through MPC Control

Eyal Dassau, Francis J. Doyle, Josep Vehí, 2008 .

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop (iDCL) Trial.

Mei Mei Church, Shelly K McCrady-Spitzer, C. Cobelli, 2020, Diabetes technology & therapeutics.

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel

Janet M. Allen, R. Hovorka, M. Wilinska, 2019, BMJ Open.

Outcome Measures for Outpatient Hypoglycemia Prevention Studies

Bruce A Buckingham, H Peter Chase, Roy W Beck, 2011, Journal of diabetes science and technology.

Use of Real-Time Continuous Glucose Monitoring Technology in Children and Adolescents

B. Buckingham, J. Block, 2008 .

R. Beck, B. Buckingham, R. Wadwa, 2021, Diabetes technology & therapeutics.

First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes

Lauren M. Huyett, Joon Bok Lee, B. Buckingham, 2020, Diabetes technology & therapeutics.

A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.

B. Buckingham, R. Wadwa, C. Kollman, 2023, Diabetes technology & therapeutics.

In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.

B. Buckingham, M. A. Wood, T. Bailey, 2018, Diabetes technology & therapeutics.

Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.

B. Buckingham, D. Maahs, S. Weinzimer, 2018, Diabetes technology & therapeutics.

The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes.

Bruce A Buckingham, Stuart A Weinzimer, Kathleen F Janz, 2006, Diabetes care.

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

C. de Beaufort, C. Cobelli, R. Hovorka, 2022, Endocrine reviews.

Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System.

R. Beck, B. Buckingham, R. Wadwa, 2021, Diabetes technology & therapeutics.

Randomized Controlled Trial of Mobile Closed-Loop Control

Mei Mei Church, F. Doyle, E. Dassau, 2020, Diabetes Care.

Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes

B. Buckingham, R. Lal, D. Morrison, 2023, Diabetes spectrum : a publication of the American Diabetes Association.

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.

Eyal Dassau, Claudio Cobelli, Marc D Breton, 2017, Diabetes technology & therapeutics.

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.

B. Buckingham, Paula K Clinton, B. Kovatchev, 2019, Diabetes technology & therapeutics.

Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study

P. Pasricha, B. Buckingham, W. Herman, 2018, PloS one.

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas

Eyal Dassau, Francis J Doyle, Ravi Gondhalekar, 2018, Journal of Diabetes Science and Technology.

Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.

Shelagh A. Mulvaney, B. Buckingham, D. Maahs, 2021, Diabetes research and clinical practice.

Automated hybrid closed‐loop control with a proportional‐integral‐derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance

Benyamin Grosman, Anirban Roy, Laurel Messer, 2017, Pediatric diabetes.

Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes

B. Wayne Bequette, Faye Cameron, Gregory P. Forlenza, 2017, Diabetes Care.

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

Eyal Dassau, Claudio Cobelli, Lalo Magni, 2014, Diabetes technology & therapeutics.

Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study.

Bruce A Buckingham, H Peter Chase, Roy W Beck, 2004, The Journal of pediatrics.

Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp

Benyamin Grosman, Bruce A. Buckingham, Anirban Roy, 2015, Diabetes Care.

A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas.

Bruce A Buckingham, Irl B Hirsch, Arturo Garcia, 2017, Diabetes technology & therapeutics.

Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.

Bruce A Buckingham, Darrell M Wilson, Roy W Beck, 2011, Diabetes technology & therapeutics.

Diabetes technology and the human factor.

B. Buckingham, M. Phillip, A Liberman, 2011, International journal of clinical practice. Supplement.

Response to nocturnal alarms using a real-time glucose sensor.

Bruce Buckingham, Darrell M Wilson, Darrell M. Wilson, 2005, Diabetes technology & therapeutics.

In Silico Preclinical Trials: Methodology and Engineering Guide to Closed-Loop Control in Type 1 Diabetes Mellitus

Eyal Dassau, Lalo Magni, Stephen D Patek, 2009, Journal of diabetes science and technology.

Modular Artificial β-Cell System: A Prototype for Clinical Research

Eyal Dassau, Francis J. Doyle, Howard Zisser, 2008 .

Duration of Nocturnal Hypoglycemia Before Seizures

Darrell M. Wilson, B. Buckingham, R. Hanås, 2008, Diabetes Care.

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration

B. Buckingham, D. Maahs, R. Slover, 2018, Pediatric diabetes.

A Closed-Loop Artificial Pancreas Based on Risk Management

Günter Niemeyer, B Wayne Bequette, Fraser Cameron, 2011, Journal of diabetes science and technology.

Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy.

B. Buckingham, J. Sebag, M. Charles, 1992, Archives of ophthalmology.

Improved Glycemia with Hybrid Closed-Loop (HCL) Versus Continuous Subcutaneous Insulin Infusion (CSII) Therapy: Results from a Randomized Controlled Trial.

J. McGill, M. Lawson, R. Vigersky, 2022, Diabetes technology & therapeutics.

Joint and Pulmonary Changes in Diabetes-Reply

B. Buckingham, C. Sandborg, J. Uitto, 1987 .

80-OR: 670G Clinical Experience

Darrell M. Wilson, B. Buckingham, D. Maahs, 2019, Diabetes.

Diabetes technology and the human factor.

Bruce Buckingham, Moshe Phillip, B. Buckingham, 2015, Diabetes technology & therapeutics.

Extended use of a new continuous glucose monitoring system with wireless data transmission in children with type 1 diabetes mellitus.

Richard E. Purvis, B. Buckingham, L. Wong, 2006, Diabetes technology & therapeutics.

Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.

B. Buckingham, J. Lum, R. Wadwa, 2023, The New England journal of medicine.

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting

B. Buckingham, Paula K Clinton, D. Maahs, 2015, Diabetes Care.

295 Pilot Study of the Safety, Feasibility, and Efficacy of Continuous Glucose Monitoring (CGM) and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG): A Multicenter, Longitudinal Trial by the NIDDK Gastroparesis Clinical Research Consortium (GPCRC)

P. Pasricha, B. Buckingham, W. Herman, 2015 .

The Surveillance Error Grid

Boris Kovatchev, David C Klonoff, David B Sacks, 2014, Journal of diabetes science and technology.

In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop.

Eyal Dassau, Francis J Doyle, Howard Zisser, 2009, Diabetes technology & therapeutics.

ONBOARD: A feasibility study of a telehealth-based continuous glucose monitoring adoption intervention for adults with type 1 diabetes.

Shelagh A. Mulvaney, B. Buckingham, D. Maahs, 2021, Diabetes Technology & Therapeutics.

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

L. Magni, C. Cobelli, B. Buckingham, 2014, Diabetes technology & therapeutics.

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.

F. Doyle, C. Cobelli, E. Dassau, 2017, Diabetes technology & therapeutics.

Evaluation of a Predictive Low-Glucose Management System In-Clinic.

B. Buckingham, S. Garg, T. Bailey, 2017, Diabetes technology & therapeutics.

Use of the Cygnus GlucoWatch biographer at a diabetes camp.

Bruce A Buckingham, Darrell M Wilson, Darrell M. Wilson, 2004, Pediatrics.

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)

Daniel Howsmon, Juergen Hahn, B. Wayne Bequette, 2017, Sensors.

Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes

Eyal Dassau, Francis J. Doyle, Marzia Cescon, 2016, Journal of diabetes science and technology.

WhiteMatter Structural Differences in Young ChildrenWith Type 1 Diabetes : A Diffusion Tensor Imaging Study

Darrell M. Wilson, A. Reiss, B. Buckingham, 2012 .

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

D. Klonoff, B. Buckingham, R. Slover, 2012, Diabetes technology & therapeutics.

ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes

B. Buckingham, M. Phillip, T. Danne, 2018, Pediatric diabetes.

Changes in beta cell function during the proximate post‐diagnosis period in persons with type 1 diabetes

R. Beck, B. Buckingham, T. Aye, 2016, Pediatric diabetes.

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

Howard C. Zisser, L. Magni, D. Raimondo, 2014, Diabetes technology & therapeutics.